Fernand Labrie
Publications
Page 1 of 4, showing 50 records out of 191 total, starting on record 1, ending on 50
| Publication | Category | Year |
|---|---|---|
| 350. Coy, D.H., Labrie, F., Savary, M., Coy, E.J., Schally, A.V. (1976) Antagonistic activity of analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Mol. Cell. Endocrinol., 5: 201-208. | Breast Cancer | 1976 |
| 351. Ferland, L., Labrie, F., Savary, M., Beaulieu, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibitory activity of analogues of luteinizing hormone-releasing hormone (LH-RH) in vitro and in vivo. Clin. Endocrinol. (Oxf.), 5: 279S-289S. | Breast Cancer | 1976 |
| 352. Labrie, F., Savary, M., Coy, D.H., Coy, E.J., Schally, A.V. (1976) Inhibition of luteinizing hormone release by analogs of luteinizing hormone-releasing hormone (LHRH) in vitro. Endocrinology, 98: 289-94. | Breast Cancer | 1976 |
| 548. Asselin, J., Labrie, F., Kelly, P.A., Philibert, D., Raynaud, J.P. (1976) Specific progesterone receptors in dimethylbenzanthracene (DMBA)-induced mammary tumors. Steroids, 27: 395-404. | Breast Cancer | 1976 |
| 551. Labrie, F., Kelly, J., Asselin, J., Raynaud, J.P. (1976) Potent inhibitory activity of a new antiestrogen, RU 16117, on the development and growth of DMBA-induced rat mammary adenocarcinoma, in: St. Arneault, G., Band, P. et Israel, L., eds: Recent results in Cancer Research, Breast Cancer, a multidisciplinary approach, Springer-Verlag, pp 109-120. | Breast Cancer | 1976 |
| 544. Asselin, J., Kelly, P.A., Caron, M.G., Labrie, F. (1977) Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology, 101: 666-671. | Breast Cancer | 1977 |
| 545. Kelly, P.A., Asselin, J., Caron, M.G., Labrie, F., Raynaud, J.P. (1977) Potent inhibitory effect of a new antiestrogen (RU16117) on the growth of 7,12-dimethylbenz(?)anthracene (DMBA)-induced mammary tumors. J. Natl. Cancer Inst., 58: 623-628. | Breast Cancer | 1977 |
| 546. Kelly, P.A., Asselin, J., Caron, M.G., Raynaud, J.P., Labrie, F. (1977) High inhibitory activity of a new antiestrogen RU16117 (11?-methoxy-ethinyl estradiol) on the development of dimethylbenz(?)anthracene-induced mammary tumors. Cancer Res., 37: 76-81. | Breast Cancer | 1977 |
| 547. Kelly, P.A., Asselin, J., Labrie, F., Raynaud, J.P. (1977) Regulation of hormone receptor levels and growth of DMBA-induced mammary tumors by RU16117 and other steroids in the rat, in: McGuire, W.L., Baulieu, E.E. et Raynaud, J.P., eds: Progesterone Receptors in Normal and Neoplastic Tissues, New-York, Raven Press, pp 85-101. | Breast Cancer | 1977 |
| 342. Auclair, C., Cusan, L., Kledzik, G.S., Ferland, L., Kelly, P.A., Labrie, F. (1978) Inhibition de fonctions gonadiques par la LHRH et ses agonistes chez le rat mâle et femelle. Union Med. Can., 107: 356-364. | Breast Cancer | 1978 |
| 542. Asselin, J., Labrie, F. (1978) Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. J. Steroid Biochem., 9: 1079-1082. | Breast Cancer | 1978 |
| 339. Cusan, L., Auclair, C., Bélanger, A., Ferland, L., Kelly, P.A., Séguin, C., Labrie, F. (1979) Inhibitory effects of long-term treatment with an LHRH agonist on the pituitary-gonadal axis in male and female rats. Endocrinology, 104: 1369-1376. | Breast Cancer | 1979 |
| 340. Labrie, F., Auclair, C., Cusan, L., Lemay, A., Pelletier, G., Kelly, P.A., Bélanger, A., Séguin, C., Raynaud, J.P. (1979) Antifertility effects of LHRH and its agonists in male and female rats: possible luteolytic effects of LHRH in women, in: Talwar, G.P., ed. Recent Advances in Reproduction and Regulation of Fertility, Elsevier-North Holland, Biomedical Press, pp 57-71. | Breast Cancer | 1979 |
| 537. Asselin, J., Mélançon, R., Moachon, G., Labrie, F. (1979) Récepteurs hormonaux, in: Dionne, L. et Plante, M., eds: Cancer du Sein: Breast Cancer, Les Presses de l'Université Laval, pp 41-46. | Breast Cancer | 1979 |
| 539. Kelly, P.A., Asselin, J., Labrie, F. (1979) Endocrine regulation of growth and hormone receptor levels in DMBA-induced mammary tumors, in: Thompson, E.B. et Lippman, M.E., eds: Steroids Receptors and the Management of Cancer, Boca Raton, Florida, CRC Press Inc., pp 3-29. | Breast Cancer | 1979 |
| 540. Kelly, P.A., Asselin, J., Turcot-Lemay, L., Labrie, F., Raynaud, J.P. (1979) Effects of progesterone and R2323 on the development of dimethylbenz(??anthracene-induced mammary tumors. Eur. J. Cancer, 15: 1243-1251. | Breast Cancer | 1979 |
| 321. Labrie, F. (1981) Changing the message from the brain. People, 8: 16-17. | Breast Cancer | 1981 |
| 323. Labrie, F., Bélanger, A., Séguin, C., Cusan, L., Pelletier, G., Lefebvre, F.A., Kelly, P.A., Ferland, L., Reeves, J.J., Lemay, A., Raynaud, J.P. (1981) Inhibition of testicular and ovarian functions by LHRH agonists, in: Jagiello, G. et Vogel, H.J., eds: Bioregulators of Reproduction, New York, NY, USA, Academic Press, pp 305-341. | Breast Cancer | 1981 |
| 324. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Kelly, P.A., Lefebvre, F.A., Massicotte, J., Borgus, J.P., Lemay, A., van der Ohe, M. (1981) Antifertility effects of LHRH agonists, in: Semm, K. et Mettler, L., eds: Proc. III World Congress on Human Reproduction, Excerta Medica, ICS 551, pp 116-125. | Breast Cancer | 1981 |
| 325. Labrie, F., Bélanger, A., Séguin, C., Pelletier, G., Lefebvre, F.A., Massicotte, J., Kelly, P.A., Borgus, J.P. (1981) LHRH and sexual functions: inhibition at the pituitary and gonadal levels, in: Bizollon, C.A., ed. Physiological peptides and new trends in radioimmunology, Elsevier-North Holland, Biomedical Press, pp 57-70. | Breast Cancer | 1981 |
| 536. Turcot-Lemay, L., Cusan, L., Séguin, C., Kelly, P.A., Labrie, F. (1981) Effect of an LHRH analog on growth and hormone receptor levels in dimethylbenz(?)anthracene-induced mammary tumors in the rat. J. Receptor Res., 2: 135-151. | Breast Cancer | 1981 |
| 531. Bélanger, A., Le Goff, J.M., Proulx, L., Caron, S., Labrie, F. (1985) Presence of C-19 steroids in mammary Shionogi carcinoma (SC 115) in castrated mice. Cancer Res., 45: 6293-6295. | Breast Cancer | 1985 |
| 262. Labrie, F., Veilleux, R. (1986) A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells. Prostate, 8: 293-300. | Breast Cancer | 1986 |
| 528. Poulin, R., Labrie, F. (1986) Stimulation of cell proliferation and estrogenic response by adrenal C19-?5-steroids in the ZR-75-1 human breast cancer cell line. Cancer Res., 46: 4933-4937. | Breast Cancer | 1986 |
| 529. Simard, J., Labrie, F., Gossard, F. (1986) Regulation of growth hormone mRNA and pro-opiomelanocortin mRNA levels by cyclic AMP in rat anterior pituitary cells in culture. DNA, 5: 263-270. | Breast Cancer | 1986 |
| 530. Spinola, P.G., Marchetti, B., Labrie, F. (1986) Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. Breast Cancer Res. Treat., 8: 241-248. | Breast Cancer | 1986 |
| 524. Luthy, I., Caron, S., Bélanger, A., Labrie, F. (1987) Effect of flutamide, a pure antiandrogen, on the pituitary-ovarian axis in the adult female rat. Gynecol. Endocrinol., 1: 151-168. | Breast Cancer | 1987 |
| 525. Poulin, R., Labrie, F. (1987) Estrogenic effect of adrenal steroids in the human mammary carcinoma cell line ZR-75-1, in: Genazzani, A.R., Volpé, A. et Facchinetti, F., eds: Proceedings of the First International Congress on Gynecological Endocrinology, London, Parthenon Publishig Group, pp 561-568. | Breast Cancer | 1987 |
| 526. Simard, J., Labrie, F. (1987) Adrenal C19-5-ene steroids induce full estrogenic responses in rat pituitary gonadotrophs. J. Steroid Biochem., 26: 539-546. | Breast Cancer | 1987 |
| 199. Bégin, D., Luthy, I.A., Labrie, F. (1988) Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro. Mol. Cell. Endocrinol., 58: 213-219. | Breast Cancer | 1988 |
| 214. Labrie, F., Veilleux, R., Fournier, A. (1988) Low androgen levels induce the development of androgen hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 1138-1147. | Breast Cancer | 1988 |
| 215. Labrie, F., Veilleux, R., Fournier, A. (1988) Maintenance of androgen responsiveness by glucocorticoids in Shionogi mammary carcinoma cells in culture. J. Natl. Cancer Inst., 80: 966-970. | Breast Cancer | 1988 |
| 218. Luthy, I., Bégin, D., Labrie, F. (1988) Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17?-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture. Endocrinology, 123: 1418-1424. | Breast Cancer | 1988 |
| 219. Luthy, I.A., Bégin, D.J., Labrie, F. (1988) Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture. J. Steroid Biochem., 31: 845-852. | Breast Cancer | 1988 |
| 224. Plante, M., Lapointe, S., Labrie, F. (1988) Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice. J. Steroid Biochem., 31: 61-64. | Breast Cancer | 1988 |
| 513. Dauvois, S., Labrie, F. (1988) Androstenedione (4-dione) is a potent stimulus for the growth of dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat, in: 1st Congress of the International Society of Gynecological Endocrinology, Crans-Montana, Switzerland, pp 626-630. | Breast Cancer | 1988 |
| 514. Labrie, F., Veilleux, R., Fournier, A. (1988) Glucocorticoids stimulate the growth of mouse mammary carcinoma Shionogi cells in culture. Mol. Cell. Endocrinol., 58: 207-211. | Breast Cancer | 1988 |
| 520. Poirier, D., Poulin, R., Labrie, F. (1988) Screening of lipoidal steroid formation in the ZR-75-1 human breast cancer cell line, in: Bresciani, F., King, R.J.B., Lippman, M.E. et Raynaud, J.P., eds: Progress in Cancer Research and Therapy. Hormones and Cancer, New York, Raven Press, pp 384-387. | Breast Cancer | 1988 |
| 521. Poulin, R., Baker, D., Labrie, F. (1988) Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast Cancer Res. Treat., 12: 213-225. | Breast Cancer | 1988 |
| 522. Poulin, R., Mérand, Y., Labrie, F. (1988) Antiestrogenic properties of a 7?-alkylated derivative of 17?-estradiol in ZR-75-1 human breast cancer, in: Genazzani, A.R., Petraglia, F., Volpe, A. et Facchinetti, F., eds: Recent Research in Gynecological Endocrinology, Parthenon Publishing Group, pp 631-634. | Breast Cancer | 1988 |
| 523. Spinola, P.G., Marchetti, B., Mérand, Y., Labrie, F. (1988) Effects of the aromatase inhibitor 4-hydroxyandrostenedione and antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors. Breast Cancer Res. Treat., 12: 287-296. | Breast Cancer | 1988 |
| 501. Dauvois, S., Labrie, F. (1989) Androstenedione and androst-5-ene-3beta, 17beta-diol stimulate DMBA-induced rat mammary tumors-role of aromatase. Breast Cancer Res. Treat., 13: 61-69. | Breast Cancer | 1989 |
| 502. Dauvois, S., Li, S., Martel, C., Labrie, F. (1989) Inhibitory effect of androgens on DMBA-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 14: 299-306. | Breast Cancer | 1989 |
| 503. Dauvois, S., Spinola, P.G., Labrie, F. (1989) Additive inhibitory effects of bromocriptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz(a)anthracene (DMBA)-induced mammary tumors in the rat. Eur. J. Cancer Clin. Oncol., 25: 891-897. | Breast Cancer | 1989 |
| 504. Dumont, M., Dauvois, S., Simard, J., Garcia, T., Schachter, B., Labrie, F. (1989) Antagonism between estrogens and androgens on GCDFP-15 gene expression in ZR-75-1 cells and correlation between GCDFP-15 and estrogen as well as progesterone receptor expression in human breast cancer. J. Steroid Biochem., 34: 397-402. | Breast Cancer | 1989 |
| 505. Marchetti, B., Spinola, P., Plante, M., Poyet, P., Folléa, N., Pelletier, G., Labrie, F. (1989) ?-adrenergic receptors in dimethylbenz(?)anthracene(DMBA)-induced rat mammary tumors: Correlation with progesterone receptor levels and tumor growth. Breast Cancer Res. Treat., 13: 251-263. | Breast Cancer | 1989 |
| 506. Poulin, R., Baker, D., Poirier, D., Labrie, F. (1989) Androgen and glucocorticoid receptor-mediated inhibition of cell proliferation by medroxyprogesterone acetate in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 13: 161-172. | Breast Cancer | 1989 |
| 507. Poulin, R., Dufour, J.-M., Labrie, F. (1989) Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin. Breast Cancer Res. Treat., 13: 265-276. | Breast Cancer | 1989 |
| 508. Poulin, R., Mérand, Y., Poirier, D., Lévesque, C., Dufour, J.M., Labrie, F. (1989) Antiestrogenic properties of keoxifene, trans-4-hydroxytamoxifen and ICI 164384, a new steroidal derivative, in ZR-75-1 human breast cancer cells. Breast Cancer Res. Treat., 14: 65-76. | Breast Cancer | 1989 |
| 509. Poulin, R., Poirier, D., Mérand, Y., Thériault, C., Bélanger, A., Labrie, F. (1989) Extensive esterification of adrenal C19-?5 sex steroids to long-chain fatty acids in the ZR-75-1 human breast cancer cell line. J. Biol. Chem., 264: 9335-9343. | Breast Cancer | 1989 |